Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cure Pharmaceutical Holding Corp (CURR)

Cure Pharmaceutical Holding Corp (CURR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 52,715
  • Shares Outstanding, K 70,475
  • Annual Sales, $ 2,050 K
  • Annual Income, $ -30,620 K
  • 60-Month Beta 1.41
  • Price/Sales 23.94
  • Price/Cash Flow N/A
  • Price/Book 1.78
Trade CURR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.51
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/20/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4823 +55.09%
on 09/01/21
0.8490 -11.90%
on 09/10/21
+0.2180 (+41.13%)
since 08/24/21
3-Month
0.4625 +61.73%
on 07/12/21
0.8490 -11.90%
on 09/10/21
+0.0981 (+15.09%)
since 06/24/21
52-Week
0.4625 +61.73%
on 07/12/21
2.1200 -64.72%
on 12/01/20
-0.5420 (-42.02%)
since 09/24/20

Most Recent Stories

More News
New Trends in Oral Thin Film Drugs Market Size 2021 | Methodology, Estimation, Research and Future Growth by 2027

Orally Dissolvable Thin Film (ODF) or sublingual/ wafers is a drug delivery mechanism, developed with paper-thin polymer films that carry pharmaceutical agents. Besides, ease in administering, ODF drugs...

ACB.TO : 7.55 (-3.08%)
CURR : 0.7480 (+7.36%)
GSK : 38.39 (-2.41%)
NVS : 82.93 (-0.77%)
PFE : 43.94 (-0.57%)
CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines

CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced results for the quarter ended June 30, 2021, including the following highlights:

CURR : 0.7480 (+7.36%)
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021

The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor...

ACOG.VN : 1.350 (-3.57%)
GET.CN : 0.285 (+1.79%)
MYID.VN : 0.370 (unch)
OSS.VN : 0.640 (unch)
TBRD.VN : 5.000 (+2.25%)
VMC.VN : 5.870 (-0.17%)
VST.CN : 0.445 (-1.11%)
WTEQ.CN : 0.105 (-4.55%)
XXII : 2.97 (-4.19%)
AYRO : 3.60 (-1.10%)
BCDA : 3.35 (-6.42%)
BLGO : 0.1835 (+0.27%)
BITF : 4.84 (-3.59%)
BAMM.CN : 0.590 (+1.72%)
BMMJ : 0.4662 (+1.17%)
BCTX : 9.19 (+10.99%)
BCTXW : 4.95 (+23.75%)
BTX : 9.48 (-5.58%)
CURR : 0.7480 (+7.36%)
DN.TO : 0.4100 (+2.50%)
DLTNF : 0.3324 (+7.23%)
SOLO : 3.54 (-0.56%)
ELLXF : 0.0720 (-9.55%)
FRSAF : 0.0101 (-15.83%)
FLGC : 6.90 (+33.72%)
GMETF : 0.2216 (-0.94%)
GBLX : 0.0365 (+7.99%)
GOVX : 4.32 (-1.14%)
GTMS.TO : 9.43 (-0.84%)
GBNH : 7.47 (-0.40%)
IFA.TO : 3.30 (unch)
IFABF : 2.5600 (-9.54%)
INND : 0.0088 (-6.38%)
ILAL : 0.7500 (-7.41%)
ISDR : 25.65 (-4.68%)
KSPN : 16.74 (-0.36%)
MYIDF : 0.2876 (+0.49%)
LEAF.TO : 2.91 (+3.19%)
LEMLF : 1.9900 (-10.36%)
LXXGF : 0.3200 (-2.26%)
LTBR : 4.92 (-4.65%)
MDP.TO : 3.01 (-1.95%)
MEDXF : 2.3600 (-0.42%)
OSSIF : 0.5035 (-0.42%)
ORGS : 4.95 (-1.00%)
PTPI : 1.9500 (+4.28%)
PRPH : 5.08 (-1.55%)
MAPPF : 0.3068 (-3.70%)
PYR : 3.99 (-3.16%)
PYR.TO : 5.04 (-3.45%)
LUKEF : 0.2291 (-0.39%)
RCRT : 3.81 (-1.55%)
RCRTW : 1.3000 (-10.34%)
RIII : 0.0440 (+12.82%)
SPVNF : 1.0509 (-0.86%)
STAF : 2.07 (-3.72%)
SPCB : 1.0300 (+1.98%)
TGCB : 0.7500 (unch)
TEKCF : 0.4175 (-12.11%)
TFFP : 8.03 (-0.99%)
THBRF : 3.9500 (+2.60%)
VENZF : 0.0693 (+4.37%)
VEV : 4.67 (+0.43%)
VSQTF : 0.3552 (+0.03%)
VIRI : 5.20 (-4.94%)
VMAR : 6.45 (-0.92%)
VNRX : 3.25 (+1.56%)
WTEQF : 0.0830 (-5.68%)
WPNDF : 1.0000 (-0.99%)
XSF.CN : 0.200 (unch)
XSHLF : 0.1514 (+1.61%)
ZIVO : 5.45 (+57.97%)
Seratopical Revolution Skincare Line by The Sera Labs Inc., a CURE Pharmaceutical Company, will be Available for Purchase this Fall at CVS, one of the Leading National Drug Store Chains

Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), today announced that all six facial products of the Seratopical Revolution skincare line will be available for purchase at CVS...

CURR : 0.7480 (+7.36%)
CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference

CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness markets, announced today...

CURR : 0.7480 (+7.36%)
CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health

CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research...

CURR : 0.7480 (+7.36%)
Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign

Sera Labs, a subsidiary of CURE Pharmaceutical Holding Corp. (OTC: CURR), announced today a new ad campaign and launch of Seratopical Revolution, a new clean, plant-based, technologically advanced, anti-aging,...

CURR : 0.7480 (+7.36%)
CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021

CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, today announced that it will hold a webcast with the investment community on Thursday,...

CURR : 0.7480 (+7.36%)
CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics

CURE Pharmaceutical Holding Corp. (OTC: CURR), a vertically integrated drug delivery and product development company, reported its financial results and provided an operational update for the first quarter...

CURR : 0.7480 (+7.36%)
CURE Pharmaceutical Receives ISO Certification for Laboratory and Manufacturing Facility

CURE Pharmaceutical Holding Corp. ("CURE" or the "Company") (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has secured International Organization...

CURR : 0.7480 (+7.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 0.8263
2nd Resistance Point 0.7877
1st Resistance Point 0.7678
Last Price 0.7480
1st Support Level 0.7093
2nd Support Level 0.6707
3rd Support Level 0.6508

See More

52-Week High 2.1200
Fibonacci 61.8% 1.4868
Fibonacci 50% 1.2912
Fibonacci 38.2% 1.0957
Last Price 0.7480
52-Week Low 0.4625

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar